Related Experiment Video
Updated: Jul 12, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Newborns with Favourable Outcomes after Perinatal Asphyxia Have Upregulated Glucose Metabolism-Related Proteins in
Ping K Yip1, Michael Bremang2, Ian Pike2
1Centre for Neuroscience, Surgery and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Insights
Therapeutic hypothermia (TH) for hypoxic-ischaemic encephalopathy (HIE) shows promise, but its mechanism is unclear. This study found upregulated glucose metabolism proteins in newborns with favorable HIE outcomes after TH, suggesting new therapeutic targets.
Area of Science:
- Biochemistry and Molecular Biology
- Neonatal Medicine
- Proteomics
Background:
- Hypoxic-ischaemic encephalopathy (HIE) is a significant global cause of newborn morbidity and mortality.
- Mild therapeutic hypothermia (TH) can improve outcomes in HIE, but its underlying mechanisms require further elucidation.
Purpose of the Study:
- To investigate the plasma proteome of newborns with HIE undergoing TH to identify mechanisms of neuroprotection.
- To compare protein profiles between HIE newborns with favorable and unfavorable outcomes following TH.
Main Methods:
- Plasma samples from newborns with moderate-severe HIE (treated with TH), mild HIE (no TH), and normal controls (cord blood) were analyzed.
- Isobaric Tandem Mass Tag (TMT®) 10plex™ labeling coupled with tandem mass spectrometry was employed for proteomic analysis.
- Bioinformatic analysis, including Gene Ontology (GO) annotation and functional clustering, was used to interpret protein data.
Main Results:
- A total of 405 proteins were identified, with distinct signatures differentiating normal cord blood from HIE groups.
- Newborns with favorable outcomes (sHIE+) after TH showed significant upregulation of glucose metabolism-related enzymes compared to those with unfavorable outcomes (sHIE-).
- Specific upregulated enzymes in the sHIE+ group included fructose-bisphosphate aldolase A, glyceraldehyde-3-phosphate dehydrogenase, and pyruvate kinase PKM, among others.
Conclusions:
- Plasma proteomic analysis reveals an upregulation of glucose metabolism pathways in newborns with favorable outcomes following TH for HIE.
- These findings suggest that enhanced glucose metabolism may be a key mechanism underlying the neuroprotective effects of TH.
- The identified proteins may serve as potential biomarkers or therapeutic targets for improving neuroprotection strategies in HIE.
Abstract:
Hypoxic-ischaemic encephalopathy (HIE) is an important cause of morbidity and mortality globally. Although mild therapeutic hypothermia (TH) may improve outcomes in selected babies, the mechanism of action is not fully understood. A proteomics discovery study was carried out to analyse proteins in the plasma of newborns with HIE. Proteomic analysis of plasma from 22 newborns with moderate-severe HIE that had initially undergone TH, and relative controls including 10 newborns with mild HIE who did not warrant TH and also cord blood from 10 normal births (non-HIE) were carried out using the isobaric Tandem Mass Tag (TMT®) 10plexTM labelling with tandem mass spectrometry. A total of 7818 unique peptides were identified in all TMT10plexTM samples, translating to 3457 peptides representing 405 proteins, after applying stringent filter criteria. Apart from the unique protein signature from normal cord blood, unsupervised analysis revealed several significantly regulated proteins in the TH-treated moderate-severe HIE group. GO annotation and functional clustering revealed various proteins associated with glucose metabolism: the enzymes fructose-bisphosphate aldolase A, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate mutase 1, phosphoglycerate kinase 1, and pyruvate kinase PKM were upregulated in newborns with favourable (sHIE+) outcomes compared to newborns with unfavourable (sHIE-) outcomes. Those with favourable outcomes had normal MR imaging or mild abnormalities not predictive of adverse outcomes. However, in comparison to mild HIE and the sHIE- groups, the sHIE+ group had the additional glucose metabolism-related enzymes upregulated, including triosephosphate isomerase, α-enolase, 6-phosphogluconate dehydrogenase, transaldolase, and mitochondrial glutathione reductase. In conclusion, our plasma proteomic study demonstrates that TH-treated newborns with favourable outcomes have an upregulation in glucose metabolism. These findings may open new avenues for more effective neuroprotective therapy.
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon
Inborn Errors of Metabolism
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

